
Avalo Therapeutics, Inc.
AVTXHealthcare|Biotechnology|US
$6.93
+0.30 (+4.52%)
DCF Value
$0.99
Tangible Book / Share
$7.74
Cash / Share
$7.14
Next Earnings Report
Mar 22, 2027
EPS est. -$0.59
Financing Filings (last 12 months)
7
Shelf registrations / offering prospectuses — latest Nov 5, 2026 (S-3ASR). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Avalo Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Updates
Nov 5, 2026 · GlobeNewsWire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Nov 2, 2026 · GlobeNewsWire
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Sep 29, 2026 · GlobeNewsWire
Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress
Sep 23, 2026 · GlobeNewsWire
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Sep 4, 2026 · GlobeNewsWire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Sep 3, 2026 · GlobeNewsWire
SEC Filings (128)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 5, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 5, 2026 | S-3ASR | Shelf registration | DocumentIndex |
| Nov 5, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 5, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Oct 29, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 7, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 7, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Jul 28, 2026 | EFFECT | DocumentIndex | |
| Jul 28, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jul 27, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 17, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jul 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jun 23, 2026 | 8-K | Material event | DocumentIndex |
| Jun 18, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jun 16, 2026 | 8-K | Material event | DocumentIndex |
| Jun 12, 2026 | 8-K | Material event | DocumentIndex |
| Jun 8, 2026 | 8-K | Material event | DocumentIndex |
| Jun 5, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 29, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 26, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |